6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01872819 [Disease Site] Acute Myeloid Leukemia [Description] 
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description